Literature DB >> 1333467

Coagulation abnormalities in liver disease.

E F Mammen1.   

Abstract

Hemostasis is intimately related to liver function, because most coagulation factors are synthesized by liver parenchymal cells and the liver's reticuloendothelial system serves an important role in the clearance of activation products. The extent of coagulation abnormalities depends upon the degree of disturbed liver function. Acute or chronic hepatocellular diseases may display decreases in the vitamin K-dependent factors (prothrombin; factors VII, IX, and X; proteins C and S), whereas other parameters remain normal. Patients with hepatic failure may present with the entire spectrum of factor deficiencies and may even develop disseminated intravascular coagulation (DIC). Patients with liver cirrhosis have a wide spectrum of abnormalities. Except for factor VIII:C and von Willebrand factor, all procoagulant and inhibitory factors are decreased, which is a reflection of impaired protein synthesis. Abnormal fibrinogen and prothrombin molecules can be identified. Platelets are quantitatively and qualitatively altered, and most patients develop DIC. Vitamin K deficiency leads to the production of abnormal vitamin K-dependent factors. The factors lack gamma-carboxy glutamic acid residues in the NH2-terminal part of their molecules. Surgery associated with the liver leads to major hemostasis alterations. The LeVeen shunt is invariably related to DIC. Bleeding with partial liver resection is mostly mechanically induced, but chronic DIC may be present. Orthotoptic liver transplantation is associated with severe hemorrhages. These are partly due to the pre-existing hemostasis defects and partly due to DIC with a marked fibrinolytic response. This is especially noted during the anhepatic phase and when the donor liver is perfused by the recipient's blood. Postoperative recovery is quick, provided the graft is not rejected. Postoperatively, there may be an initial hypercoagulable state, which could be related to the thrombosis occasionally encountered.

Entities:  

Mesh:

Year:  1992        PMID: 1333467

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  18 in total

Review 1.  Mechanisms and cell signaling in alcoholic liver disease.

Authors:  Juliane I Beier; Craig J McClain
Journal:  Biol Chem       Date:  2010-11       Impact factor: 3.915

Review 2.  Hepatic actinomycosis: case report and review of the literature in Japan.

Authors:  S Sugano; T Matuda; T Suzuki; H Makino; M Iinuma; K Ishii; K Ohe; K Mogami
Journal:  J Gastroenterol       Date:  1997-10       Impact factor: 7.527

Review 3.  Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Walter Ageno; Alexander S Gallus; Ann Wittkowsky; Mark Crowther; Elaine M Hylek; Gualtiero Palareti
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

4.  SOD1 nanozyme salvages ischemic brain by locally protecting cerebral vasculature.

Authors:  Yuhang Jiang; Anna M Brynskikh; Devika S-Manickam; Alexander V Kabanov
Journal:  J Control Release       Date:  2015-06-18       Impact factor: 9.776

5.  Monitoring coagulation proteins during progression of liver disease.

Authors:  Mohamed Hessien; Mohamed Ayad; Wafaa M Ibrahim; Batoul Izz ulArab
Journal:  Indian J Clin Biochem       Date:  2014-04-19

6.  Blood Component Utilization for Disseminated Intravascular Coagulation (DIC) Cases with Respect to Underlying Condition.

Authors:  Snehalata C Gupte; Abhay G Jhaveri
Journal:  Indian J Hematol Blood Transfus       Date:  2015-04-25       Impact factor: 0.900

7.  Serotype-specific host responses in rhesus macaques after primary dengue challenge.

Authors:  Andrew C Hickey; Jacob A Koster; Claudia M Thalmann; Kathy Hardcastle; Phaik-Hooi Tio; Mary J Cardosa; Katharine N Bossart
Journal:  Am J Trop Med Hyg       Date:  2013-09-23       Impact factor: 2.345

8.  Impact of sustained virus elimination on natural anticoagulant activity in patients with chronic viral hepatitis C.

Authors:  Aida Saray; Rusmir Mesihović; Zora Vukobrat-Bijedić; Srđan Gornjaković; Nenad Vanis; Amila Mehmedović; Vedad Papović; Sanjin Glavaš
Journal:  Bosn J Basic Med Sci       Date:  2013-05       Impact factor: 3.363

9.  Haemostatic Profile of Patients with Chronic Liver Disease- its Correlation with Severity and Outcome.

Authors:  Varnika Rai; Neeraj Dhameja; Sandip Kumar; Jyoti Shukla; Rajeev Singh; Vinod Kumar Dixit
Journal:  J Clin Diagn Res       Date:  2017-08-01

10.  The incidence of venous thromboembolism and practice of deep venous thrombosis prophylaxis in hospitalized cirrhotic patients.

Authors:  Abdulaziz Aldawood; Yaseen Arabi; Abdulrahman Aljumah; Alawi Alsaadi; Asgar Rishu; Hasan Aldorzi; Saad Alqahtani; Mohammad Alsultan; Afaf Felemban
Journal:  Thromb J       Date:  2011-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.